Rational engineering of antibody therapeutics targeting multiple oncogene pathways
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rational engineering of antibody therapeutics targeting multiple oncogene pathways
Authors
Keywords
-
Journal
mAbs
Volume 3, Issue 3, Pages 299-309
Publisher
Informa UK Limited
Online
2011-07-07
DOI
10.4161/mabs.3.3.15299
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies
- (2011) Weirong Wang et al. MOLECULAR IMMUNOLOGY
- Inhibition of IGF1R activity enhances response to trastuzumab in HER-2-positive breast cancer cells
- (2010) B. C. Browne et al. ANNALS OF ONCOLOGY
- Activating KRAS Mutations and Overexpression of Epidermal Growth Factor Receptor as Independent Predictors in Metastatic Colorectal Cancer Patients Treated With Cetuximab
- (2010) Li-Chen Yen et al. ANNALS OF SURGERY
- An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation
- (2010) B. Schoeberl et al. CANCER RESEARCH
- Heterotrimerization of the Growth Factor Receptors erbB2, erbB3, and Insulin-like Growth Factor-I Receptor in Breast Cancer Cells Resistant to Herceptin
- (2010) X. Huang et al. CANCER RESEARCH
- Targeting Multiple Kinase Pathways: A Change In Paradigm
- (2010) L. Gossage et al. CLINICAL CANCER RESEARCH
- New Strategies in Head and Neck Cancer: Understanding Resistance to Epidermal Growth Factor Receptor Inhibitors
- (2010) L. F. Chen et al. CLINICAL CANCER RESEARCH
- Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory Review
- (2010) P Zhao et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Stable IgG-like Bispecific Antibodies Directed toward the Type I Insulin-like Growth Factor Receptor Demonstrate Enhanced Ligand Blockade and Anti-tumor Activity
- (2010) Jianying Dong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects
- (2010) Kannan Gunasekaran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- or Panitumumab-Refractory Metastatic Colorectal Cancer
- (2010) Diane Lauren Reidy et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTβR
- (2010) Jennifer S. Michaelson et al. mAbs
- Bispecific antibodies for cancer therapy
- (2010) Patrick Chames et al. mAbs
- Predictive tools for stabilization of therapeutic proteins
- (2010) Vladimir Voynov et al. mAbs
- Enhanced antibody half-life improves in vivo activity
- (2010) Jonathan Zalevsky et al. NATURE BIOTECHNOLOGY
- Development trends for human monoclonal antibody therapeutics
- (2010) Aaron L. Nelson et al. NATURE REVIEWS DRUG DISCOVERY
- Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm
- (2010) Erik Kvam et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Stability engineering of scFvs for the development of bispecific and multivalent antibodies
- (2010) Brian R. Miller et al. PROTEIN ENGINEERING DESIGN & SELECTION
- SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies†
- (2010) Jonathan H. Davis et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Future Novel Single Agent and Combination Therapies
- (2009) Diana Cirstea et al. CANCER JOURNAL
- Bispecific T-Cell Engaging Antibodies for Cancer Therapy
- (2009) P. A. Baeuerle et al. CANCER RESEARCH
- Breast cancer biomarkers and HER2 testing after 10 years of anti-HER2 therapy
- (2009) J.S. Ross DRUG NEWS & PERSPECTIVES
- The Design and Characterization of Oligospecific Antibodies for Simultaneous Targeting of Multiple Disease Mediators
- (2009) Nazzareno Dimasi et al. JOURNAL OF MOLECULAR BIOLOGY
- Aggregation-Prone Motifs in Human Immunoglobulin G
- (2009) Naresh Chennamsetty et al. JOURNAL OF MOLECULAR BIOLOGY
- High-Throughput Thermal Scanning: A General, Rapid Dye-Binding Thermal Shift Screen for Protein Engineering
- (2009) Jason J. Lavinder et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Protein tyrosine sulfation: A critical posttranslation modification in plants and animals
- (2009) K. L. Moore PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A modular IgG-scFv bispecific antibody topology
- (2009) Kelly Davis Orcutt et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Structural understanding of stabilization patterns in engineered bispecific Ig-like antibody molecules
- (2009) Jacob L. Jordan et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site
- (2009) J. Bostrom et al. SCIENCE
- Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor-PI3K Axis
- (2009) B. Schoeberl et al. Science Signaling
- Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro
- (2008) M K Robinson et al. BRITISH JOURNAL OF CANCER
- MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
- (2008) H. Jin et al. CANCER RESEARCH
- Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins
- (2008) Alain Beck et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- O-Fucosylation of an antibody light chain: Characterization of a modification occurring on an IgG1 molecule
- (2008) J. F Valliere-Douglass et al. GLYCOBIOLOGY
- The way forward, enhanced characterization of therapeutic antibody glycosylation: Comparison of three level mass spectrometry-based strategies
- (2008) Elsa Wagner-Rousset et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer
- (2008) J. Randolph Hecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Conserved amino acid networks involved in antibody variable domain interactions
- (2008) Norman Wang et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Transient Gene Expression in Suspension HEK-293 Cells: Application to Large-Scale Protein Production
- (2005) Lucia Baldi et al. BIOTECHNOLOGY PROGRESS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started